CardioPharma Overview

  • Year Founded
  • 2006

Year Founded

  • Status
  • Private

  • Employees
  • 3

Employees

  • Latest Deal Type
  • Series A

  • Investors
  • 1

CardioPharma General Information

Description

Developer of cardiovascular drugs intended to reduce the morbidity of cardiovascular disease. The company's drug helps to control cholesterol levels and blood pressure levels, enabling patients to reduce the risk of heart diseases.

Contact Information

Website
www.cardio-pharma.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 100-A Eastwood Center Drive
  • Suite 117
  • Wilmington, NC 28403
  • United States
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Vertical(s)
Life Sciences
Corporate Office
  • 100-A Eastwood Center Drive
  • Suite 117
  • Wilmington, NC 28403
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

CardioPharma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Early Stage VC (Series A) 02-Jan-2012 Completed Startup
To view CardioPharma’s complete valuation and funding history, request access »

CardioPharma Patents

  • 9

    Total Documents Applications and Grants

  • Total Patents Families

  • 6

    Granted

  • 3

    Pending

  • Expiring in next 12 mo

CardioPharma Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2019441241-A1 Anti-hypertensive and cholesterol-lowering fixed-dose combination and method of manufacture Active 17-Apr-2019
EP-3955912-A1 Anti-hypertensive and cholesterol-lowering fixed-dose combination and method of manufacture Pending 17-Apr-2019
EP-3955912-A4 Anti-hypertensive and cholesterol-lowering fixed-dose combination and method of manufacture Pending 17-Apr-2019
CA-3136797-A1 Anti-hypertensive and cholesterol-lowering fixed-dose combination and method of manufacture Active 17-Apr-2019
US-20200330391-A1 Anti-hypertensive and cholesterol-lowering fixed-dose combination and method of manufacture Active 17-Apr-2019 A61K9/2095
To view CardioPharma’s complete patent history, request access »

CardioPharma Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

CardioPharma Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
Zoticon Bioventures Venture Capital Minority
To view CardioPharma’s complete investors history, request access »

Ready to get started?

Request a free trial

CardioPharma FAQs

  • When was CardioPharma founded?

    CardioPharma was founded in 2006.

  • Where is CardioPharma headquartered?

    CardioPharma is headquartered in Wilmington, NC.

  • What is the size of CardioPharma?

    CardioPharma has 3 total employees.

  • What industry is CardioPharma in?

    CardioPharma’s primary industry is Drug Discovery.

  • Is CardioPharma a private or public company?

    CardioPharma is a Private company.

  • What is CardioPharma’s current revenue?

    The current revenue for CardioPharma is .

  • Who are CardioPharma’s investors?

    Zoticon Bioventures has invested in CardioPharma.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »